Angelis, Aris, Polyakov, Roman, Wouters, Olivier J., Torreele, Els and McKee, Martin (2023) High drug prices are not justified by industry’s spending on research and development. BMJ, 380 (8371). ISSN 1756-1833
![[img]](http://eprintstest.lse.ac.uk/style/images/fileicons/text.png) |
Text (High drug prices are not justified by industry’s spending on research and development)
- Accepted Version
Download (586kB) |
Identification Number: https://doi.org/10.1136/bmj-2022-071710
Abstract
Aris Angelis and colleagues argue that by refocusing their spending drug companies could provide more innovative drugs at affordable prices
| Item Type: | Article |
|---|---|
| Official URL: | https://www.bmj.com/ |
| Additional Information: | © 2023 BMJ. |
| Divisions: | Health Policy |
| Subjects: | R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine > RM Therapeutics. Pharmacology |
| Date Deposited: | 09 Jan 2023 14:18 |
| Last Modified: | 20 Sep 2025 02:19 |
| URI: | http://eprintstest.lse.ac.uk/id/eprint/117809 |
Actions (login required)
 |
View Item |
